Latest Capital Raises News

Element 25 Limited reports a transformative quarter with a 142% resource increase at Butcherbird, a compelling $561 million NPV feasibility study, and a $268 million US Department of Energy grant to advance its Louisiana battery-grade manganese refinery.

Farm Pride Foods has successfully recovered from Avian Influenza setbacks, improving cash flows and repaying significant debt while investing in biosecurity and production upgrades.

Suvo Strategic Minerals delivered a robust December quarter with soaring profits and an extended supply deal, while advancing innovative low carbon cement projects in Australia and Indonesia.

AML3D Limited has reported a strong December quarter marked by significant defense contract completions, a $30 million capital raise, and strategic expansion into the US and European markets. The company is poised for accelerated growth, underpinned by a major US Navy funding boost and new sector entries.

Element 25 Limited has successfully raised AU$2.85 million through an at-the-market share placement with Acuity Capital, issuing 8.7 million shares at a premium price to bolster its working capital.

Murray Cod Australia Ltd has secured a $43 million funding package from Westpac, advancing its Stanbridge site construction and expanding its biomass. The company also initiated exports to Thailand and is progressing towards entry into the Chinese market.

Prodigy Gold's December 2024 quarterly report reveals significant high-grade gold intercepts at its Hyperion and Tregony projects, alongside progress on metallurgical testing and a new Mineral Lease application. The company maintains a solid cash position with no debt, positioning itself for an active 2025 exploration season.

FirstWave reports a stable Q2 FY25 with no cash burn for the second consecutive quarter, maintaining cash reserves at $1.68 million while securing key client contract renewals and launching a promising new product.

MRG Metals reports significant progress in its Mozambique Heavy Mineral Sands joint venture with Sinowin Lithium, alongside promising rare earth element exploration results in Zimbabwe, positioning the company for potential growth in strategic mineral markets.

ioneer Ltd’s December 2024 quarterly cash flow report reveals ongoing cash outflows from operations and investing, with nearly $4.5 million spent this quarter but a solid cash reserve providing a runway of almost five quarters.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.

A1 Investments & Resources Ltd reported a modest cash outflow for Q1 2024 while actively pursuing renewable energy acquisitions in Japan and Australia, contingent on regulatory approvals and shareholder consent.